0001562180-22-004762.txt : 20220603
0001562180-22-004762.hdr.sgml : 20220603
20220603160833
ACCESSION NUMBER: 0001562180-22-004762
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220601
FILED AS OF DATE: 20220603
DATE AS OF CHANGE: 20220603
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Weaver Dennis
CENTRAL INDEX KEY: 0001844219
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40154
FILM NUMBER: 22994422
MAIL ADDRESS:
STREET 1: C/O OSCAR HEALTH, INC.
STREET 2: 75 VARICK STREET, 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10013
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oscar Health, Inc.
CENTRAL INDEX KEY: 0001568651
STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 75 VARICK STREET
STREET 2: 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10013
BUSINESS PHONE: (646) 403-3677
MAIL ADDRESS:
STREET 1: 75 VARICK STREET
STREET 2: 5TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10013
FORMER COMPANY:
FORMER CONFORMED NAME: Mulberry Health Inc.
DATE OF NAME CHANGE: 20130204
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2022-06-01
false
0001568651
Oscar Health, Inc.
OSCR
0001844219
Weaver Dennis
75 VARICK STREET, 5TH FLOOR
NEW YORK
NY
10013
false
true
false
false
Chief Clinical Officer
Class A Common Stock
2022-06-01
4
M
false
2004.00
A
15369.00
D
Class A Common Stock
2022-06-01
4
M
false
4167.00
A
19536.00
D
Class A Common Stock
2022-06-02
4
S
false
1548.00
4.6869
D
17988.00
D
Restricted Stock Units
2022-06-01
4
M
false
2004.00
0.00
D
Class A Common Stock
2004.00
26059.00
D
Restricted Stock Units
2022-06-01
4
M
false
4167.00
0.00
D
Class A Common Stock
4167.00
45834.00
D
Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
The sale was effected pursuant to a Rule 10b5-1 instruction letter to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.68 to $4.741, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price at which the transactions were effected.
The restricted stock units vest in sixteen equal quarterly installments beginning on December 1, 2021.
The restricted stock units vest in sixteen equal quarterly installments beginning on June 1, 2021.
/s/ Melissa Curtin, Attorney-in-fact
2022-06-03